We will conduct descriptive analyses to characterize the sample stratified by pediatric and adult cases. We will report demographics, symptom patterns, onset, course of illness, comorbid psychiatric conditions, neurodevelopmental characteristics, environmental exposures, and health-related quality of life in child (parent/guardian and child report) and adult ARFID cases.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.